Positive feedback system provides efficient and persistent transgene expression

Molecular Pharmaceutics

Volumn 7, Issue 4, 2010, Pages 1125-1132

  Ochiai, Hiroshi ^a,b   Harashima, Hideyoshi ^a,b   Kamiya, Hiroyuki ^a,b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

artificial transcription factor; Long term transgene expression; positive feedback system

Indexed keywords

ALBUMIN; HYBRID PROTEIN; LUCIFERASE; PLASMID DNA; PROTEIN VP16; TRANSCRIPTION FACTOR GAL4;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; FEMALE; GENE EXPRESSION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LIVER; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN BINDING; REPORTER GENE; TRANSGENE;

ANIMALS; BINDING SITES; DNA-BINDING PROTEINS; FEMALE; GENES, REPORTER; HELA CELLS; HUMANS; LIVER; LUCIFERASES; MICE; MICE, INBRED BALB C; SACCHAROMYCES CEREVISIAE PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSGENES;

EID: 77955265560     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp1000108     Document Type: Article

References (36)

1. Kamiya, H.; Akita, H.; Harashima, H. Pharmacokinetic and pharmacodynamic considerations in gene therapy Drug Discovery Today 2003, 8, 990-996
2. Ochiai, H.; Harashima, H.; Kamiya, H. Intranuclear dispositions of exogenous DNA in vivo: silencing, methylation and fragmentation FEBS Lett. 2006, 580, 918-922
3. Ochiai, H.; Fujimuro, M.; Yokosawa, H.; Harashima, H.; Kamiya, H. Transient activation of transgene expression by hydrodynamics-based injection may cause rapid decrease in plasmid DNA expression Gene Ther. 2007, 14, 1152-1159
4. Herweijer, H.; Zhang, G.; Subbotin, V. M.; Budker, V.; Williams, P.; Wolff, J. A. Time course of gene expression after plasmid DNA gene transfer to the liver J. Gene Med. 2001, 3, 280-291
5. Yew, N. S.; Zhao, H.; Przybylska, M.; Wu, I. H.; Tousignant, J. D.; Scheule, R. K.; Cheng, S. H. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo Mol. Ther. 2002, 5, 731-738
6. Hodges, B. L.; Taylor, K. M.; Joseph, M. F.; Bourgeois, S. A.; Scheule, R. K. Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides Mol. Ther. 2004, 10, 269-278
7. Chen, Z. Y.; He, C. Y.; Ehrhardt, A.; Kay, M. A. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo Mol. Ther. 2003, 8, 495-500
8. Chen, Z. Y.; He, C. Y.; Meuse, L.; Kay, M. A. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo Gene Ther. 2004, 11, 856-864
9. AlinÌo, S. F.; Crespo, A.; Dasié, F. Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA Gene Ther. 2003, 10, 1672-1679
10. Hama, S.; Akita, H.; Ito, R.; Mizuguchi, H.; Harashima, H. Quantitative comparison of intracellular trafficking and nuclear transcription between adenoviral and lipoplex systems Mol. Ther. 2006, 13, 786-794
11. Sadowski, I.; Ma, J.; Triezenberg, S.; Ptashne, M. GAL4-VP16 is an unusually potent transcriptional activator Nature 1988, 335, 563-564
12. Fang, B.; Ji, L.; Bouvet, M.; Roth, J. A. Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery J. Biol. Chem. 1998, 273, 4972-4975
13. Iyer, M.; Wu, L.; Carey, M.; Wang, Y.; Smallwood, A.; Gambhir, S. S. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 14595-14600
14. Sato, M.; Johnson, M.; Zhang, L.; Zhang, B.; Le, K.; Gambhir, S. S.; Carey, M.; Wu, L. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy Mol. Ther. 2003, 8, 726-737
15. van Gaal, E. V.; Hennink, W. E.; Crommelin, D. J.; Mastrobattista, E. Plasmid engineering for controlled and sustained gene expression for nonviral gene therapy Pharm. Res. 2006, 23, 1053-1074
16. Nettelbeck, D. M.; Jéroìme, V.; Müller, R. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters Gene Ther. 1998, 5, 1656-1664
17. Woraratanadharm, J.; Rubinchik, S.; Yu, H.; Fan, F.; Morrow, S. M.; Dong, J. Y. Highly specific transgene expression mediated by a complex adenovirus vector incorporating a prostate-specific amplification feedback loop Gene Ther. 2004, 11, 1399-1407
18. Gorski, K.; Carneiro, M.; Schibler, U. Tissue-specific in vitro transcription from the mouse albumin promoter Cell 1986, 47, 767-776
19. Kramer, M. G.; Barajas, M.; Razquin, N.; Berraondo, P.; Rodrigo, M.; Wu, C.; Qian, C.; Fortes, P.; Prieto, J. In vitro and in vivo comparative study of chimeric liver-specific promoters Mol. Ther. 2003, 7, 375-385
20. Wooddell, C. I.; Reppen, T.; Wolff, J. A.; Herweijer, H. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery J. Gene Med. 2008, 10, 551-563
21. Liu, F.; Song, Y.; Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA Gene Ther. 1999, 6, 1258-1266
22. Zhang, G.; Budker, V.; Wolff, J. A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA Hum. Gene Ther. 1999, 10, 1735-1737
23. Emami, K. H.; Carey, M. A synergistic increase in potency of a multimerized VP16 transcriptional activation domain EMBO J. 1992, 11, 5005-5012
24. Carey, M.; Leatherwood, J.; Ptashne, M. A potent GAL4 derivative activates transcription at a distance in vitro Science 1990, 247, 710-712
25. Tantin, D.; Chi, T.; Hori, R.; Pyo, S.; Carey, M. Biochemical mechanism of transcriptional activation by GAL4-VP16 Methods Enzymol. 1996, 274, 133-149
26. Mittler, G.; Stühler, T.; Santolin, L.; Uhlmann, T.; Kremmer, E.; Lottspeich, F.; Berti, L.; Meisterernst, M. A novel docking site on Mediator is critical for activation by VP16 in mammalian cells EMBO J. 2003, 22, 6494-6504
27. Yang, F.; DeBeaumont, R.; Zhou, S.; Näär, A. M. The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 2339-2344
28. Tumbar, T.; Sudlow, G.; Belmont, A. S. Large-scale chromatin unfolding and remodeling induced by VP16 acidic activation domain J. Cell Biol. 1999, 145, 1341-1354
29. Black, J. C.; Choi, J. E.; Lombardo, S. R.; Carey, M. A mechanism for coordinating chromatin modification and preinitiation complex assembly Mol. Cell 2006, 23, 809-818
30. Labow, M. A.; Baim, S. B.; Shenk, T.; Levine, A. J. Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells Mol. Cell. Biol. 1990, 10, 3343-3356
31. Baim, S. B.; Labow, M. A.; Levine, A. J.; Shenk, T. A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl Β-D-thiogalactopyranoside Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 5072-5076
32. Gossen, M.; Freundlieb, S.; Bender, G.; Müller, G.; Hillen, W.; Bujard, H. Transcriptional activation by tetracycline in mammalian cells Science 1995, 268, 1766-1769
33. Gossen, M.; Bujard, H. Tight control of gene expression in mammalian cells by tetracycline responsive promoters Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 5547-5551
34. Wang, Y.; O'Malley, B. W., Jr.; Tsai, S. Y.; O'Malley, B. W. A regulatory system for use in gene transfer Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 8180-8184
35. Wolff, L. J.; Wolff, J. A.; Sebestyén, M. G. Effect of tissue-specific promoters and microRNA recognition elements on stability of transgene expression after hydrodynamic naked plasmid DNA delivery Hum. Gene Ther. 2009, 20, 374-388
36. Miao, C. H.; Ohashi, K.; Patijn, G. A.; Meuse, L.; Ye, X.; Thompson, A. R.; Kay, M. A. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro Mol. Ther. 2000, 1, 522-532